2011
DOI: 10.1074/mcp.m110.000679
|View full text |Cite
|
Sign up to set email alerts
|

Rare Cell Proteomic Reactor Applied to Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC)-based Quantitative Proteomics Study of Human Embryonic Stem Cell Differentiation

Abstract: The molecular basis governing the differentiation of human embryonic stem cells (hESCs) remains largely unknown. Systems-level analysis by proteomics provides a unique approach to tackle this question. However, the requirement of a large number of cells for proteomics analysis (i.e. 10 6 -10 7 cells) makes this assay challenging, especially for the study of rare events during hESCs lineage specification. Here, a fully integrated proteomics sample processing and analysis platform, termed rare cell proteomic rea… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
78
0
1

Year Published

2011
2011
2015
2015

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 57 publications
(79 citation statements)
references
References 53 publications
(37 reference statements)
0
78
0
1
Order By: Relevance
“…cells with different arginine isotopes (using a SILACbased proteomics approach), and then pooled the samples for HLA-B27 peptide isolation and MS/MS analysis (24,25). Arginine was selected for SILAC isotope labeling because it is a dominant "anchor" amino acid at position 2 (P2) of HLA-B27 peptide ligands (26-28), whereas it is not an anchor residue for the other alleles expressed (HLA-Cw*04 and HLA-B*35), albeit at low levels, in C1R cells (29)(30)(31).…”
Section: Erap1 In Hla-b27 Peptide Presentation 287mentioning
confidence: 99%
“…cells with different arginine isotopes (using a SILACbased proteomics approach), and then pooled the samples for HLA-B27 peptide isolation and MS/MS analysis (24,25). Arginine was selected for SILAC isotope labeling because it is a dominant "anchor" amino acid at position 2 (P2) of HLA-B27 peptide ligands (26-28), whereas it is not an anchor residue for the other alleles expressed (HLA-Cw*04 and HLA-B*35), albeit at low levels, in C1R cells (29)(30)(31).…”
Section: Erap1 In Hla-b27 Peptide Presentation 287mentioning
confidence: 99%
“…Several approaches such as denaturant-assisted lysis, acetone precipitation, filter-aided sample preparation, and monolithic microreactor-based techniques have been developed for processing small amounts of sample, for example 500 -1000 cultured cells (15)(16)(17). However, these methodologies only allow identification of a few hundred proteins at these levels.…”
mentioning
confidence: 99%
“…Because of the small dimension of these devices, they are readily able to integrate into nanoLC workflows. Various applications have been described including increasing proteome coverage (22,27,28) and targeting of phosphopeptides (24,31,32), glycopeptides and released glycans (29,33,34).…”
mentioning
confidence: 99%